Phibro Issues Inaugural Environmental, Social and Governance Report
Phibro Animal Health Corporation (NASDAQ: PAHC) released its inaugural Environmental, Social and Governance (ESG) Report, establishing baseline key performance metrics as of December 31, 2021. The Report aligns with the Sustainability Accounting Standards Board (SASB) and Global Reporting Initiative (GRI) frameworks, highlighting Phibro’s commitment to sustainable animal health. The company emphasizes its responsibility to provide safe, affordable protein sustainably as global demand rises. Phibro plans to regularly review and update its ESG metrics.
- Inaugural ESG Report aligns with SASB and GRI frameworks, demonstrating commitment to sustainability.
- Highlights the company's efforts in empowering employees and engaging communities.
- Potential risks related to the FDA withdrawal of approval for the Mecadox product, which may impact financial projections.
“This first ESG Report demonstrates the commitment of the entire Phibro team. Throughout history, raising healthy animals has been foundational to a healthy, affordable food supply and ultimately, to our survival as a civilization. As the world population grows and challenges mount, we at Phibro have a responsibility to meet the demand for safe, affordable protein and do it more sustainably,” commented
Phibro intends to review progress against the metrics contained in the Report regularly, and to publish revisions periodically.
To read Phibro Animal Health Corporation’s inaugural ESG Report, please visit https://www.pahc.com/responsibility
About
Forward-Looking Statements: This communication contains forward-looking statements that are subject to risks and uncertainties, including risks relating to the potential FDA withdrawal of approval of our Mecadox (carbadox) product. All statements other than statements of historical or current fact included in this communication are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. These statements are not guarantees of future performance or actions. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Phibro expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Quarterly Report on Form 10-Q and Annual Report on Form 10-K, including in the sections thereof captioned “Forward-Looking Statements” and “Risk Factors.” These filings and subsequent filings are available online at www.sec.gov, www.pahc.com, or on request from Phibro.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220609005998/en/
Chief Financial Officer,
+1 201-329-7300
investor.relations@pahc.com
Source:
FAQ
What is Phibro Animal Health Corporation's stock symbol?
When was Phibro's first ESG Report published?
What frameworks does Phibro's ESG Report align with?